Floatz logo

7-((3-CHLORO-6,11-DIHYDRO-6-METHYLDIBENZO(C,F)(1,2)THIAZEPIN-11-YL)AMINO)HEPTANOIC ACID S,S-DIOXIDE

Post-mastectomy Pain Syndrome

National Cancer Institute, EgyptSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Post-mastectomy Pain Syndrome cohort.

Asset / SponsorPhaseRating
LIDOCAINE
University Health Network, Toronto
Phase 3BB
Pregabalin
National Cancer Institute, Egypt
Phase 3B
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
National Cancer Institute, Egypt
N/AD
MAGNESIUM METALLICUM
South Egypt Cancer Institute
N/AD
Duloxetine
National Cancer Institute, Egypt
N/AD

Same molecule, other indications

7-((3-CHLORO-6,11-DIHYDRO-6-METHYLDIBENZO(C,F)(1,2)THIAZEPIN-11-YL)AMINO)HEPTANOIC ACID S,S-DIOXIDE is also rated in:

major depressive disorderDormant
BB
Indicative ·
68 / 100
View asset →
major depressive disorderDormant
B
Indicative ·
62 / 100
View asset →
bipolar disorderDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →